PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
142 hedge funds and large institutions have $428M invested in Progenics Pharmaceuticals Inc in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less call options, than puts
Call options by funds: $1.81M | Put options by funds: $2.78M
Holders
142
Holding in Top 10
1
Calls
$1.81M
Puts
$2.78M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$1.5M | |
| 3 | +$1.47M | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$1.41M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.28M |
Top Sellers
| 1 | -$6.79M | |
| 2 | -$6.16M | |
| 3 | -$3.87M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.54M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.89M |